Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Puma Biotechnology, Inc. (NASDAQ: PBYI)
PBYI Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-27.70%
Analyst Rating:
NOT AVAILABLE
Analyst Forecast (1yr):
NOT AVAILABLE
PBYI Stock Analysis
PBYI
PE Ratio:
14.2
PBYI
PEG Ratio:
-0.5
PBYI
Forward EPS Growth (12 month):
-31.00%
PBYI
PS Ratio:
1.5
PBYI
PSG Ratio:
-1.1
PBYI
Forward Revenue Growth (12 month):
-1.40%
PBYI Articles
No data was found